Cornerstone Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
607
+31
| +5% | +$12.6K | 0.01% | 566 |
|
|
2025
Q1 | $287K | Sell |
576
-154
| -21% | -$76.7K | 0.02% | 486 |
|
|
2024
Q4 | $380K | Buy |
730
+101
| +16% | +$52.5K | 0.03% | 416 |
|
|
2024
Q3 | $389K | Sell |
629
-20
| -3% | -$12.4K | 0.03% | 404 |
|
|
2024
Q2 | $359K | Buy |
649
+51
| +9% | +$28.2K | 0.03% | 398 |
|
|
2024
Q1 | $348K | Sell |
598
-62
| -9% | -$36K | 0.03% | 403 |
|
|
2023
Q4 | $350K | Sell |
660
-44
| -6% | -$23.4K | 0.03% | 389 |
|
|
2023
Q3 | $356K | Buy |
704
+16
| +2% | +$8.1K | 0.03% | 384 |
|
|
2023
Q2 | $359K | Sell |
688
-1
| -0.1% | -$522 | 0.03% | 367 |
|
|
2023
Q1 | $397K | Buy |
+689
| New | +$397K | 0.04% | 325 |
|
|
2022
Q3 | $699K | Buy |
1,379
+18
| +1% | +$9.12K | 0.08% | 205 |
|
|
2022
Q2 | $739K | Buy |
1,361
+394
| +41% | +$214K | 0.08% | 197 |
|
|
2022
Q1 | $571K | Sell |
967
-120
| -11% | -$70.9K | 0.06% | 257 |
|
|
2021
Q4 | $725K | Buy |
1,087
+359
| +49% | +$239K | 0.07% | 231 |
|
|
2021
Q3 | $416K | Buy |
728
+20
| +3% | +$11.4K | 0.04% | 301 |
|
|
2021
Q2 | $357K | Buy |
708
+99
| +16% | +$49.9K | 0.04% | 344 |
|
|
2021
Q1 | $278K | Sell |
609
-88
| -13% | -$40.2K | 0.03% | 366 |
|
|
2020
Q4 | $325K | Buy |
697
+139
| +25% | +$64.8K | 0.04% | 319 |
|
|
2020
Q3 | $247K | Buy |
+558
| New | +$247K | 0.04% | 338 |
|
|
2019
Q2 | – | Sell |
-524
| Closed | -$250K | – | 488 |
|
|
2019
Q1 | $250K | Buy |
+524
| New | +$250K | 0.03% | 435 |
|
|
2018
Q4 | – | Sell |
-69,468
| Closed | -$359K | – | 1061 |
|
|
2018
Q3 | $359K | Buy |
69,468
+3,133
| +5% | +$16.2K | ﹤0.01% | 1013 |
|
|
2018
Q2 | $322K | Buy |
+66,335
| New | +$322K | ﹤0.01% | 1168 |
|